New Drug Could Reduce Damaging Brain Inflammation after a TBI

Posted on February 22, 2016 by Disability Help Group

Brain inflammation is one of the biggest risks following a traumatic brain injury (TBI). A study recently published in the PLOS One medical journal took a look at the mechanisms that cause brain inflammation and looked for a way to block the process.

The researchers found that when a head injury occurs, the immune system sends special immune cells to respond to the trauma and begin repairs. The cells dispatched help repair any damage to the brain, but may also cause inflammation that may cause a different type of long-term damage.

A drug known as MW151 showed great promise in trials with mouse models suffering a mild fluid percussion injury. The type of brain injury the mice models sustained is representative of a diffuse axonal injury, a severe form of TBI in humans. Administration of the MW151 drug to the injured mice allowed the brain repair to continue while suppressing inflammation.

The reduction of inflammation is an integral factor in reducing the risk of cognitive impairment because even though the injury may have completely healed, the associated mental trauma can last a lifetime. Many survivors of severe TBI lose memory function, emotional control, and suffer from other cognitive disorders.

After a Severe TBI, Your Loved One May Qualify for Disability Benefits

Traumatic brain injury survivors who experience severe cognitive impairment to the point where they can no longer work and earn a substantial income may qualify for Social Security disability benefits. Disability Help Group is here to assist with appeals or filing difficult applications. Contact us online or call us at 1-(800)-800-3332 to schedule a consultation with our disability advocates!